These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12021632)

  • 1. C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects.
    Min DI; Ellingrod VL
    Ther Drug Monit; 2002 Jun; 24(3):400-4. PubMed ID: 12021632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the effect of MDR1 C3435T polymorphism on cyclosporine pharmacokinetics.
    Jiang ZP; Wang YR; Xu P; Liu RR; Zhao XL; Chen FP
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):433-44. PubMed ID: 18801030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects.
    Min DI; Ellingrod VL; Marsh S; McLeod H
    Ther Drug Monit; 2004 Oct; 26(5):524-8. PubMed ID: 15385835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the CYP3A4*1B 5'-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjects.
    Min DI; Ellingrod VL
    Ther Drug Monit; 2003 Jun; 25(3):305-9. PubMed ID: 12766558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.
    Balram C; Sharma A; Sivathasan C; Lee EJ
    Br J Clin Pharmacol; 2003 Jul; 56(1):78-83. PubMed ID: 12848778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
    Wang Y; Wang C; Li J; Wang X; Zhu G; Chen X; Bi H; Huang M
    Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of MDR1 polymorphic expression on oral disposition of cyclosporine A].
    Jiao Z; Liang HQ; Ding JJ; Li ZD; Shi XJ; Zhong MK
    Yao Xue Xue Bao; 2004 Dec; 39(12):971-4. PubMed ID: 15813023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A4∗18B and CYP3A5∗3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects.
    Tao XR; Xia XY; Zhang J; Tong LY; Zhang W; Zhou X; Liu ZH; Song HT
    Eur J Pharm Sci; 2015 Aug; 76():238-44. PubMed ID: 25976223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.
    Guo X; Chen XP; Cheng ZN; Luo X; Guo R; Chen L; Chen J; Chen B; Peng J; Li YJ
    Clin Chem Lab Med; 2009; 47(1):38-43. PubMed ID: 19072027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients.
    Yates CR; Zhang W; Song P; Li S; Gaber AO; Kotb M; Honaker MR; Alloway RR; Meibohm B
    J Clin Pharmacol; 2003 Jun; 43(6):555-64. PubMed ID: 12817518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients.
    Chowbay B; Cumaraswamy S; Cheung YB; Zhou Q; Lee EJ
    Pharmacogenetics; 2003 Feb; 13(2):89-95. PubMed ID: 12563178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
    Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
    Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males.
    Zhang WX; Chen GL; Zhang W; Tan ZR; Liu J; Zhou G; Hu DL; Zhou HH
    Clin Chim Acta; 2005 Sep; 359(1-2):46-52. PubMed ID: 16170863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers.
    Ansermot N; Rebsamen M; Chabert J; Fathi M; Gex-Fabry M; Daali Y; Besson M; Rossier M; Rudaz S; Hochstrasser D; Dayer P; Desmeules J
    Drug Metab Lett; 2008 Apr; 2(2):76-82. PubMed ID: 19356075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
    Liu XL; Tang J; Song J; He J; Xu P; Peng WX
    Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of genetic polymorphisms of CYP2C19*2/*3 and MDR1 C3435T on the pharmacokinetics of lansoprazole in healthy Chinese subjects.
    Zhang YX; Wei SJ; Yang XY; Zhang WP; Wang XY; Dang HW
    Int J Clin Pharmacol Ther; 2014 Oct; 52(10):850-5. PubMed ID: 25109411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.